JAK Inhibitors for the Treatment of Vitiligo: Current Evidence and Emerging Therapeutic Potential
César Ferreira, Brett King, Tiago Torres
Topics & Concepts
MedicineRuxolitinibVitiligoTofacitinibSorafenibJanus kinaseCalcineurinDrug repositioningClinical trialSirolimusOncologyTargeted therapyPimecrolimusHepatocellular carcinomaPharmacologyDrug developmentstatAdalimumabInternal medicineMelanomaDrugAnakinraCancer researchImmunologyDermatologyBioinformaticsTacrolimusCombination therapyCytokineDaclizumabmelanin and skin pigmentationGarlic and Onion StudiesHerpesvirus Infections and Treatments